Llwytho...
Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
Background: Although the introduction of protease inhibitor bortezomib (BTZ) and immunomodulatory agent lenalidomide has led to improved outcomes in patients with multiple myeloma (MM), the disease remains incurable. Gambogenic acid (GNA), a polyprenylated xanthone isolated from the traditional Chin...
Wedi'i Gadw mewn:
Cyhoeddwyd yn: | J Cancer |
---|---|
Prif Awduron: | , , , , |
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Ivyspring International Publisher
2017
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381173/ https://ncbi.nlm.nih.gov/pubmed/28382147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17657 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|